F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interviews and record review, the facility failed to provide pharmaceutical services (including procedures
that assure the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals to
meet the needs of each resident for five (Resident #1, Resident #2, Resident #3, Resident #4, and
Resident #5) of five residents reviewed for pharmacy services.
The facility failed to ensure that documentation of narcotic medications signed out on the narcotic count
sheet were consistent with documentation of narcotic medications administered to Resident #1, Resident
#2, Resident #3, Resident #4, and Resident #5 as reflected on their MAR and nursing progress notes.
These failures could place residents at risk for medication errors, potentially leading to overdose of narcotic
pain medications, or diversion of narcotic pain medications.
Findings included:
1) Record review of Resident #1's admission Record dated 4/23/25 reflected a [AGE] year-old female
initially admitted to the facility om 12/23/24 and readmitted on [DATE].
Record review of Resident #1's Quarterly MDS assessment dated [DATE] reflected she had a BIMS score
of 5 indicating severe cognitive impairment. Her diagnoses included hypertension (high blood pressure);
Multi-drug resistant organism (an infection resistant to many types of antibiotics); stroke; non-Alzheimer's
dementia (neurodegenerative disease causing dementia that is not Alzheimer's disease); and inflammatory
spondylopathy lumbar region (autoimmune disease that affects the spine and surrounding joints causing
inflammation and pain).
Record review of Resident #1's Order Summary Report dated 4/23/25 reflected an order for Tramadol Hcl
(a controlled pain medication) oral tablet 50 mg. Give one tablet by mouth every 8 hours for pain.
Record review of Resident #2's Individual Control Drug Record for Tramadol Hcl tab 50 mg dated 2/16/25
reflected the medication was signed out on the following dates:
2/20/25 at 5:00 PM by LVN A
2/22/25 at 7:00 AM by LVN B
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 10
Event ID:
675112
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
2/22/25 at 1:00 PM by LVN B
Level of Harm - Minimal harm
or potential for actual harm
2/22/25 at 7:00 PM by LVN B
2/23/25 at 7:00 AM by LVN B
Residents Affected - Some
2/23/25 at 1:00 PM by LVN B
2/23/25 at 7:00 PM by LVN B
2/24/25 at 9:00 PM by LVN A
2/26/25 at 6:00 PM by LVN A
3/2/25 at 7:00 AM by LVN B
3/2/25 at 1:00 PM by LVN B
3/2/25 at 7:00 PM by LVN B
3/5/25 at 4:22 PM by LVN A
3/8/25 at 7:00 AM by LVN B
3/8/25 at 1:00 PM by LVN B
3/8/25 at 7:00 PM by LVN B
3/9/25 at 7:00 AM by LVN B
3/9/25 at 1:00 PM by LVN B
3/9/25 at 7:00 PM by LVN B
Record review of Resident #1's Licensed Nurse MAR for February 2025 reflected an entry for Tramadol Hcl
50 mg Tab give 1 tablet every 6 hours as needed for pain. No doses were signed as administered by LVN A
or LVN B on 2/20/25; 2/22/25; 2/23/25; 2/24/25; 2/25/25; 3/2/25; 3/5/25; or 3/9/25. One dose was signed as
administered by LVN B on 3/8/25 at 9:51 AM.
Record review of Resident #1's EMR reflected the following entries:
3/8/25 at 9:51 AM: Medication Administration Note: Tramadol Hcl 50 MG give one tablet by mouth every 6
hours as needed for pain. Signed by LVN B.
3/8/25 at 1:00 PM: .No s/sx of pain or discomfort ate [sic] this time. Signed by LVN B.
3/8/25 at 2:47 PM: Medication Administration Note: Tramadol Hcl 50 MG give one tablet by mouth every 6
hours as needed for pain. PRN Medication was: Effective.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 2 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
No other nursing notes were found related to the medications signed out on Resident #1's Individual
Control Drug Record.
Observation and interview on 4/22/25 at 4:15 AM revealed Resident #1 was awake and sitting up in bed.
She was confused and disoriented to place and time. She denied complaints of pain other than occasional
pain when repositioning. Resident #1 was unable to answer questions related to her medications.
2) Record review of Resident #2's admission Record dated 4/23/25 reflected a [AGE] year-old male
admitted to the facility on [DATE].
Record review of Resident #2's Quarterly MDS assessment dated [DATE] reflected a BIMS score of 15
indicating his cognition was intact. His diagnoses included history of a stroke with left-side hemiparesis
(weakness or paralysis on one side of the body); colon cancer; muscle weakness and high blood pressure.
Record review of Resident #2's Order Summary Report dated 4/23/25 reflected an order for Tylenol with
Codeine #3 (a controlled pain medication) 300-30 mg one tablet by mouth every 8 hours as needed for
pain.
Record review of Resident #2's Individual Control Drug Record for APAP/Codeine [Tylenol with codeine] tab
300-30mg initiated 2/15/25 reflected the medication was signed out on the following dates:
2/22/25 at 8:00 AM by LVN B
2/22/25 at 8:00 PM by LVN B
2/23/25 at 8:00 AM by LVN B
2/23/25 at 8:00 PM by LVN B
3/2/25 at 8:00 PM by LVN B
3/8/25 at 8:00 PM by LVN B
3/9/25 at 8:00 PM by LVN B
Record review of Resident #2's Licensed Nurse MAR for February 2025 reflected no Tylenol with Codeine
was signed as administered on 2/22/25 or 2/23/25.
Record review of Resident #2's Licensed Nurse MAR for March 2025 reflected no Tylenol with Codeine was
signed as administered on any date in March 2025.
Record review of Resident #2's EMR reflected there were no entries located within his nursing progress
notes related to the administration of Tylenol with codeine between 2/22/25 and 3/9/25.
During an observation and interview on 2/22/24 at 7:11 AM, Resident #2 was observed sitting up in bed
eating breakfast. He stated he took pain medication on occasion and never had any difficulty getting his
medication when needed. He was unable to recall the last time he needed pain medications and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 3 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
stated he had some good days and some bad days.
Level of Harm - Minimal harm
or potential for actual harm
3) Record review of Resident #3's admission Record dated 4/23/25 reflected a [AGE] year-old female
admitted to the facility 10/5/24.
Residents Affected - Some
Record review or Resident #3's Annual MDS assessment dated [DATE] reflected she had a BIMS score of
14 indicating she was cognitively intact.
Record review of Resident #3's Order Summary Report dated 4/23/25 reflected an order for Tylenol with
codeine #3 300-30 mg give 1 tablet by mouth every 6 hours as needed for pain.
Record review of Resident #3's Individual Control Drug Record for APAP/Codeine [Tylenol with codeine] tab
300-30mg dated 2/1/25 reflected the medication was signed out as administered on the following dates:
2/11/25 at 12:00 PM by LVN A
2/15/25 at 8:00 AM by LVN B
2/15/25 at 7:00 PM by LVN B
2/16/25 at 8:00 AM by LVN B
2/16/25 at 2:00 PM by LVN B
2/16/25 at 8:00 PM by LVN B
2/22/25 at 7:00 AM by LVN B
2/22/25 at 5:00 PM by LVN B
2/23/25 at 7:00 AM by LVN B
2/25/25 at 7:00 PM by LVN A
3/2/25 at 7:00 AM by LVN B
3/2/25 at 5:00 PM by LVN B
3/6/25 at 8:48 PM by LVN A
3/8/25 at 7:00 AM by LVN B
3/8/25 at 5:00 PM by LVN B
Record review of Resident #3's Licensed Nurse MAR for February 2025 reflected an entry for Tylenol with
Codeine #3 tablet 300-30 mg give 1 tablet every 6 hours as needed for pain. No doses were signed as
administered on 2/11/25; 2/16/25; 2/23/25; or 2/25/25. One dose was signed as administered on 2/15/25 at
9:32 PM by LVN B and one dose was signed as administered on 2/22/25 at 10:29 AM by LVN B.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 4 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Record review of Resident #3's Licensed Nurse MAR for March 2025 reflected an entry for Tylenol with
Codeine #3 tablet 300-30 mg give 1 tablet every 6 hours as needed for pain. No doses were signed as
administered on 3/2/25 or 3/6/25. One dose was signed as administered on 3/8/22 at 10:05 AM by LVN B.
Record review of Resident #3's EMR reflected there were no entries located within his nursing progress
notes related to the administration of Tylenol with codeine on 2/11/25; 2/16/25; 2/23/25; 2/25/25; 3/2/25; or
3/6/25. One nursing Medication Administration Note was entered on 3/8/22 at 10:05 AM by LVN B reflecting
she received 1 tablet of Tylenol with Codeine #3 300-30 mg.
During an interview on 4/22/25 at 7:15 AM, Resident #3 denied any concerns related to her pain
management.
4) Record review of Resident #4's admission Record dated 4/23/25 reflected a [AGE] year-old female
initially admitted to the facility on [DATE].
Record review of Resident #4's Quarterly MDS assessment dated [DATE] reflected she had a BIMS score
on 14 indicating she was cognitively intact. Her diagnoses included coronary artery disease (narrowing of
the arteries in the heart); hypertension; peripheral vascular disease (narrowing of the blood vessels outside
the heart and brain affecting blood flow); stroke, hemiplegia (weakness or paralysis on one side of the body
often the result of a stroke); and pain.
Record review of Resident #4's Order Summary Report dated 4/23/25 reflected an order for
hydrocodone/APAP 7.5/325 mg 1 tablet every 6 hours as needed for pain.
Record review of Resident #4's Individual Control Drug Record for hydrocodone/APAP 7.5/325 mg dated
2/11/25 reflected the medication was signed out as administered on the following dates:
2/12/25 at 3:00 PM by LVN A
2/13/25 at 4:00 AM by LVN C
2/13/25 at 9:14 PM by LVN A
2/14/25 at 10:00 AM by LVN A
2/14/25 at 4:00 PM by LVN A
2/15/25 at 7:00 AM by LVN B
2/15/25 at 1:00 PM by LVN B
2/15/25 at 7:00 PM by LVN B
2/16/25 at 6:00 AM by LVN B
2/16/25 at 12:00 PM by LVN B
2/16/25 at 6:00 PM by LVN B
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 5 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
2/18/25 at 5:12 PM by LVN A
Level of Harm - Minimal harm
or potential for actual harm
2/19/25 at 3:18 PM by LVN A
2/19/25 at 11:30 PM by LVN C
Residents Affected - Some
2/20/25 at 3:50 PM by LVN A
2/22/25 at 1:00 PM by LVN B
2/22/25 at 7:00 PM by LVN B
2/23/25 at 7:00 AM by LVN B
2/23/25 at 1:00 PM by LVN B
2/23/25 at 7:00 PM by LVN B
2/25/25 at 9:35 PM by LVN A
2/27/25 at 5:00 PM by LVN A
2/27/25 at 11:20 PM by LVN C
2/28/25 at 5:48 PM by LVN C
3/2/25 at 7:00 AM by LVN B
3/2/25 at 1:00 PM by LVN B
3/2/25 at 7:00 PM by LVN B
3/3/25 at 4:00 PM by LVN A
3/5/25 at 8:45 PM by LVN A
3/6/25 at 5:33 PM by LVN A
3/8/25 at 8:00 AM by LVN B
3/8/25 at 2:00 PM by LVN B
3/8/25 at 8:00 PM by LVN B
3/9/25 at 7:00 AM by LVN B
3/9/25 at 1:00 PM by LVN B
3/9/25 at 7:00 PM by LVN B
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 6 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Record review of Resident #4's Licensed Nurse MAR for February 2025 reflected an entry for Norco oral
tablet 7.5-325 mg (hydrocodone/acetaminophen) 1 tablet every 6 hours as needed for pain. No doses were
signed as administered on 2/13/25; 2/14/25; 2/15/25; 2/16/25; 2/18/25; 2/19/25; 2/20/25; 2/23/25; 2/27/25; or
2/28/25. One dose was signed as administered on 2/22/25 at 7:00 AM by LVN B; on 2/25/25 at 3:37 PM by
LVN A.
Residents Affected - Some
Record review of Resident #4's Licensed Nurse MAR for March 2025 reflected an entry for Norco oral
tablet 7.5-325 mg (hydrocodone/acetaminophen) 1 tablet every 6 hours as needed for pain. No doses were
signed as administered on 3/2/25; 3/3/25; 3/6/25; and 3/6/25. One dose was signed as administered on
3/8/25 at 9:47 AM by LVN B; and on 3/6/25 at 10:21 AM.
Record review of Resident #4's EMR reflected there were no entries located within his nursing progress
notes related to the administration of hydrocodone on 2/13/25; 2/14/25; 2/15/25; 2/16/25; 2/18/25; 2/19/25;
2/20/25; 2/23/25; 2/27/25; 2/28/25; 3/2/25; 3/3/25; 3/6/25; and 3/6/25.
During an interview on 4/23/25 at 1:54 PM, Resident #4 stated she always received her pain medications
when requested. She stated she suffered from frequent leg pain related to her vascular disease and poor
circulation and was scheduled for surgery soon.
5) Record review of Resident #5's admission Record dated 4/23/25 reflected a [AGE] year-old female
initially admitted to the facility on [DATE].
Record review of Resident #5's Quarterly MDS assessment dated [DATE] reflected she had a BIMS score
of 9 indicating moderately impaired cognition. Her diagnoses included, heart failure (condition where the
heart does not pump properly); hypertension; stroke, kidney failure, non-Alzheimer's dementia and chronic
pain.
Record review of Resident #5's Order Summary Report dated 4/23/25 reflected an order for Tylenol with
codeine #3 300-30 mg give 1 tablet by mouth every 6 hours as needed for pain.
Record review of Resident #5's Individual Control Drug Record for APAP/Codeine [Tylenol with codeine] tab
300-30mg dated 1/14/25 reflected the medication was signed out as administered on the following dates:
2/9/25 at 6:00 PM by LVN B
2/15/25 at 8:00 AM by LVN B
2/15/25 at 7:00 PM by LVN B
2/16/25 at 8:00 AM by LVN B
2/16/25 at 7:00 PM by LVN B
2/22/25 at 8:00 AM by LVN B
2/22/25 at 7:00 PM by LVN B
2/23/25 at 8:00 AM by LVN B
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 7 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
2/23/25 at 7:00 PM by LVN B
Level of Harm - Minimal harm
or potential for actual harm
3/2/25 at 7:00 PM by LVN B
3/8/25 at 7:00 AM by LVN B
Residents Affected - Some
3/8/25 at 7:00 PM by LVN B
3/11/25 at 8:30 PM by LVN A
Record review of Resident #5's Licensed Nurse MAR for February 2025 reflected an entry for Tylenol with
Codeine #3 tablet 300-30 mg give 1 tablet every 6 hours as needed for pain. No doses were signed as
administered on 2/9/25; 2/15/25; 2/16/25; or 2/23/25. One dose was signed as administered on 2/22/25 at
8:36 AM.
Record review of Resident #5's Licensed Nurse MAR for March 2025 reflected an entry for Tylenol with
Codeine #3 tablet 300-30 mg give 1 tablet every 6 hours as needed for pain. No doses were signed as
administered on 3/2/25; 3/8/25; or 3/11/25.
Record review of Resident #5's EMR reflected there were no entries located within his nursing progress
notes related to the administration of Tylenol with codeine on 2/9/25; 2/15/25; 2/16/25; 2/23/25; 3/2/25;
3/8/25; or 3/11/25. One nursing Medication Administration Note was entered on 2/22/25 at 8:36 AM by LVN
B reflecting she received 1 tablet of Tylenol with Codeine #3 300-30 mg.
During an interview on 4/23/25 at 2:26 PM, Resident #5 stated she had chronic pain and believed it was
managed well. She denied concerns and stated the staff brought her medications when she requested it.
During an interview on 4/22/25 at 5:35 AM, LVN C stated staff were required to count controlled
medications anytime they were passing their keys onto another nurse for any reason. They reviewed the
control drug record and compared the count on the page to the number of medications in their carts. LVN C
stated she had recently noticed some staff had been signing out a lot of medications for residents. She
noticed they were not always signed out on the MAR and there were no nurses' notes written. She stated
she reported the issue to her DON because it could sometimes indicate a drug diversion. She stated the
DON investigated the issue immediately. She did not recall the name of the staff member but stated they no
longer worked there. LVN C stated the DON had conducted in-service training for all the nurses and
discussed the importance of documenting medication administration especially pain meds. She stated she
realized she had missed a few MAR entries herself and believed she may have become distracted at the
time of the administrations. LVN C stated documenting medications on the MARs and progress notes was
important for assessing pain and communicating with other nurses and physicians about the residents'
needs. She stated she had not received any complaints from residents related to their pain management.
During an interview on 4/22/25 at 5:48 AM, LVN D stated she had not had any complaints or concerns from
her residents related to pain management. She stated they had recently received in-service training from
the DON related to the importance of documenting all medications administered in the MAR and nurses'
notes and to report any unusual situations with their controlled medications. LVN D stated proper
documentation was important because other nurses and physicians review the MARs and notes and it
could help identify a change in a resident's condition.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 8 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
In an interview on 4/22/25 at 7:21 AM, the DON stated LVN C had approached her about her concerns
related to the control records and LVN B, and she immediately started an investigation. She stated she
became concerned about a possible drug diversion because the same nurse was pulling controlled
medications for all her residents on her shifts. She stated she reported it to the Administrator and the State.
She stated LVN B was immediately suspended and no longer worked for the facility. The DON stated she
had conducted in-service training for all nursing staff and would provide her documentation.
During an interview on 4/22/25 at 8:14 AM, the Administrator stated he and the DON had conducted the
investigation and in-service training related to a possible drug diversion. He stated LVN D had denied any
wrongdoing and no longer worked for the facility. He stated he believed the risk to residents was theft of
medications and residents not having the medications they needed. He did not believe any residents had
missed any doses of medications and could not confirm any theft.
Record review of a written statement dated 3/14/25 and provided by LVN B reflected, [LVN B Statement] I
did my pain assessments Q shift, if they are above a 4 [on a 1-10 scale for pain-10 being most severe] I
give pain medicine. I have done this my whole career and there has never been an issue. I feel if the pain is
not controlled, the resident will act out. Signed by LVN B.
Attempts to reach LVN B on 4/23/25 at 11:25 AM and 11:35 AM via telephone were unsuccessful. A
message was left via voice mail and no call was received prior to exiting the facility.
During an interview and record on 4/23/25 at 1:00 PM, the DON reviewed the sampled residents Control
Drug Records, MARs, and nurses notes. She stated there were two main staff, LVN B and LVN A. LVN B
had been terminated and LVN A just quit this week by failing to show up to work or call in. She stated LVN A
had not responded to her phone calls. The DON stated, immediately after the allegation, she did a facility
wide audit of all the controlled medications ensuring medication counts and reviewing the nurse's
documentation. She stated she had notified the pharmacy consultant as well who assisted with the review.
The DON stated all controlled medication counts were correct and all medications were accounted for. She
stated she found multiple instances where LVN A and LVN B had failed to properly document the PRN
medications in the resident's MAR and progress notes. She stated she found a few instances with other
nurses, but they were rare. The DON stated she checked on every resident cared for by LVN A and LVN B
and none of them had any complaints related to unrelieved pain or lack of medications. She initiated
in-service training for all nurses and medication aides. The DON stated the in-service training included the
facility's pharmacy policy, and the importance of proper documentation of medication administration. She
stated the risk for failing to document on the MAR and progress notes included a medication error if a nurse
was unaware a resident had already received pain medication. She stated the physicians and pharmacy
consultants reviewed the MARs as well and may be unaware of a resident's needs. The DON stated the
nurses were responsible for ensuring their documentation was complete and policies were followed. She
stated she and the pharmacy consultant regularly monitored controlled medications during their monthly
reviews.
Attempts to reach LVN A on 4/23/25 at 1:36 PM and 1:45 PM were unsuccessful. Message was left via
voicemail and no call was received prior to exiting the facility.
During an observation, interview, and record review on 4/23/25 at 2:10 PM, LVN F and RN E were
observed counting controlled medications on the 400 Hall nurse's medication cart. No medication
discrepancies were observed during the count. LVN F stated she had recently received in-service training
related to pharmacy services. She stated she had not received any complaints from resident related to
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 9 of 10
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675112
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Coral Rehabilitation and Nursing of Arlington
1112 Gibbins Rd
Arlington, TX 76011
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
their medication regimen. LVN F stated it was very important to document any medications administered
immediately after a resident takes the medication. She stated the risk was failing to document an
assessment and not having a record available for other nurses and the physicians.
During an observation, interview and record review on 4/23/25 at 3:04 PM, RN G reviewed and counted the
controlled medications within her 300 Hall nursing medication cart. She stated she had received in-service
training recently related to pharmacy services and the importance of documenting all PRN medications on
the MAR and in the nurses' notes. She stated she documented in the MAR immediately after giving any
medications. She stated the risk included other nurses following her may be unaware of medications
received by the resident and physicians reviewed their documents as well. She stated there was a risk for
medication errors and drug diversions.
Record review of in-service documents dated 3/13/25 reflected topics included: All PRN medications must
be signed out on the MAR and on the narcotic count sheet. All medications must be counted at the
beginning and end of every shift; The MAR and Narcotic count sheet should match; the 5 rights to
medications administration; and medication destruction procedures; and the pharmacy services policy. The
attached signature sheets included the names and signatures of all facility nurses and medication aides.
Record review of the facility's policy and procedure titled, Administering Medications, dated Revised
December 2009 reflected: Policy Statement: Medications shall be administered in a safe and timely
manner, and as prescribed. Policy Interpretation and Implementation: .2. The Director of Nursing Services
will supervise and direct all nursing personnel who administer medications and/or have related functions. 3.
Medications must be administered in accordance with the orders, including any required time frame .12.
The individual administering the medication must initial the resident's MAR on the appropriate line after
giving each medication and before administering the next ones.
Record review of the facility's policy and procedure titled, Pharmacy Services Overview, dated Revised
April 2007 reflected the following: Policy Statement: The facility shall accurately and safely provide or obtain
pharmacy services, including the provision of routine and emergency medications and biologicals, and the
services of a licensed Pharmacist. Policy Interpretation and Implementation: .3. The facility shall contract
with a licensed Pharmacist to help it obtain and maintain timely and appropriate pharmacy services that
support residents' needs, are consistent with current standards of practice, and meet state and federal
requirements. This includes, but is not limited to, collaborating with the facility and Medical Director to:
Develop, implement, evaluate, and revise (as necessary) the procedures for the provision of all aspects of
pharmacy services (including ordering, delivery and acceptance, storage, distribution, preparation,
dispensing, administration, disposal, documentation, and reconciliation of all medications and biologicals in
the facility; .f. help the facility assure that medications are requested, received, and administered in a timely
manner as ordered by authorized prescribers; g. Give the facility's Director of Nursing Services, Medical
Director, and staff feedback about performance and practices related to medication administration and
medication errors; .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675112
If continuation sheet
Page 10 of 10